BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $141,000 | -48.2% | 49,900 | -34.4% | 0.05% | -66.7% |
| Q4 2018 | $272,000 | +11.5% | 76,075 | -1.6% | 0.14% | +50.0% |
| Q3 2018 | $244,000 | +3.0% | 77,325 | -4.2% | 0.10% | -5.9% |
| Q2 2018 | $237,000 | +17.9% | 80,725 | -1.2% | 0.10% | +1.0% |
| Q1 2018 | $201,000 | -15.5% | 81,725 | 0.0% | 0.10% | -7.3% |
| Q4 2017 | $238,000 | -6.7% | 81,725 | -11.9% | 0.11% | +0.9% |
| Q3 2017 | $255,000 | -1.5% | 92,725 | -2.6% | 0.11% | -15.6% |
| Q2 2017 | $259,000 | +57.9% | 95,225 | 0.0% | 0.13% | +77.8% |
| Q1 2017 | $164,000 | +57.7% | 95,225 | -4.0% | 0.07% | +35.8% |
| Q4 2016 | $104,000 | -69.4% | 99,225 | -15.6% | 0.05% | -68.6% |
| Q3 2016 | $340,000 | +11.1% | 117,607 | -0.1% | 0.17% | -0.6% |
| Q2 2016 | $306,000 | -0.3% | 117,707 | -1.5% | 0.17% | -21.3% |
| Q1 2016 | $307,000 | +8.5% | 119,507 | -28.1% | 0.22% | +10.2% |
| Q4 2015 | $283,000 | -32.6% | 166,307 | -26.0% | 0.20% | -30.0% |
| Q3 2015 | $420,000 | -48.7% | 224,607 | -0.4% | 0.28% | -46.4% |
| Q2 2015 | $819,000 | -2.4% | 225,607 | +7.0% | 0.52% | -5.4% |
| Q1 2015 | $839,000 | – | 210,807 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venor Capital Management LP | 12,005,453 | $20,409,000 | 10.92% |
| Coliseum Capital Management, LLC | 5,622,410 | $9,558,000 | 4.30% |
| Alta Fundamental Advisers LLC | 2,217,164 | $3,769,000 | 4.07% |
| WYNNEFIELD CAPITAL INC | 3,800,000 | $6,460,000 | 2.37% |
| ARDSLEY ADVISORY PARTNERS LP | 5,280,000 | $8,976,000 | 1.40% |
| NORTH TIDE CAPITAL, LLC | 3,000,000 | $5,100,000 | 0.78% |
| Camber Capital Management LP | 10,180,000 | $17,306,000 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 310,500 | $528,000 | 0.54% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 233,280 | $397,000 | 0.19% |
| Eidelman Virant Capital | 140,000 | $238,000 | 0.16% |